Asahi Glass Group. MolMed is a biotechnology company focused on research development production and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Asahi Glass Co NSG Group Guardian Glass and End-User SWOT Analysis in Industry 2026 Published.
At its core is a world-leading supplier of flat automotive and display glass chemicals and other high-tech materials and components. Asahi Glass Co Ltd invested about USD 1748 million to relocate a float furnace and mirror manufacturing facility from the Jakarta Plant to the Cikampek Plant PT Asahimas Flat Glass in 2017. The float furnace for the manufacturing of architectural glass and mass production is scheduled to commence in 2019.
Beginning with the Asahi Glass Company the AGC Group business today extends into over 30 countries with regional pillars in JapanAsia Europe and North and South America with a total of over 210 companies and approximately 50000 group employees worldwide.
Our product solutions spanning the entire breadth of automotive architectural and consumer glass are designed to deliver aesthetics and functional benefits. It also provides consumer glass offerings in the form of. AGC Biologics has acquired Molecular Medicine SpA. July 13 2021 at 1151.